From Parkinson’s to Alzheimer’s, neurodegenerative diseases are on the rise — yet few therapies exist to combat them. That’s why the Collaborative Pairs program at CZI’s Neurodegeneration Challenge Network (NDCN) is bringing together scientists to explore new ideas and new approaches.
Stanford researchers Wah Chiu and Serena Yeung bring unconventional perspectives to bear on brain research. He has been pioneering the use of cryo-electron microscopy to see molecules at the atomic scale. She explores new approaches to artificial intelligence and machine learning for biomedicine and healthcare. Their joint technical expertise could reveal the inner workings of neurons in unprecedented detail, as part of a new project supported by the NDCN.
Get to know how the NDCN empowers scientists to pursue bold ideas in order to accelerate the science of neurodegeneration — and ultimately, the path to treatments.
Imagine an alien visiting a city on Earth for the first time. How would it make sense of everything going on?
Neuroscience has a similar problem. Despite a lot of technological progress, people don’t really know all the details of what happens inside a neuron.
If we want to understand how the brain works and how to fix it, we need better ways to look inside it and its cells.
Microscopes can show us some pieces, including individual molecules. But putting the pieces together is complicated.
We think artificial intelligence (AI) can help. We are not neuroscientists. But we have a lot of friends who are!
We’re applying computer vision, a field of AI that enables computers and systems to derive meaningful information from digital images, captured from microscopes, to identify and classify molecules and their interactions.
This will allow us to compare healthy cells to unhealthy cells with mutations linked to Huntington’s disease. Our findings can also help us develop data and workflows that could open the opportunity for broader application of computer vision and deep learning algorithms to other neurodegenerative diseases.
News
Back to allMarch 12, 2020
CZI’s response to COVID-19
CZI co-founders Mark Zuckerberg and Priscilla Chan and the CZ Biohub's Joe DeRisi talk about how we're responding to the coronavirus pandemic.
Blog
July 30, 2020
Fighting to cure ALS and find #curesforall with Brian Wallach
The Chan Zuckerberg Initiative interviews Brian Wallach of I AM ALS, who is leading the fight to cure the rare neurodegenerative disease ALS.
Blog
April 09, 2024
How AI can uncover the laws of biology
Priscilla Chan reflects on CZI’s AI strategy for science, including the organization’s vision to build predictive models of cells to help scientists...
Blog
Stay up-to-date on the latest news, publications, competitions, and stories from CZ Biohub.
Cookies and JavaScript are required to access this form.